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The diagnosis of barbiturate intoxication is usually made from circumstantial evidence coupled with a characteristic, if non-specific, clinical picture. The need for a confirmatory laboratory test is often felt. Riley, Krause, Steadman, Hunter, and Hodge (1940) have described the shortcomings of the commonly used cobalt co'our reactions. The extraction of barbiturate crystals and the determination of their melting point must remain the most satisfactory method of analysis for medico-legal work, but this technique is limited in clinical practice by the large quantities of biological material required and by the time involved in the extraction and purification processes.
During the past decade research has proceeded along a number of lines, including ultra-violet and infra-red spectroscopy, x-ray crystallography, and paper chromatography. Most attention has been directed to ultra-violet spectrophotometry, which is at present the most practicable procedure in view of available suitable equipment. The details of procedure and the form of the absorption curve are similar for all but the thio-barbiturates, which absorb in a different region of the spectrum, but the general shape of the absorption curve is of some, though limited, qualitative value in identifying the particular barbiturate present.
The ultra-violet absorption spectra of barbiturate compounds have of course been known for many years. In 1940 Stuckey studied the absorption of a number of derivatives in acid and alkaline solution and came to important conclusions about their characteristics from which he suggested that the technique might be applicable to the analysis of tissues containing barbiturate. At the same time Elvidge (1940) assayed barbiturate tablets by this method. Jailer and Goldbaum (1946) and Walker, Fisher, and McHugh (1948) subsequently applied the principle to medical problems. Born (1949) in London, and Lous (1950) in Copenhagen, developed similar methods. All these methods depend on the fact that both the position and height of the absorption maximum shown by barbiturate is a function of pH, and also that most barbiturates show negligible absorption at wavelengths greater than 235 m/L for pH values below 6.0.
The technique which we have employed is based on published methods, and aims to combine a reasonable degree of accuracy with a minimum of procedure. By its use it is possible to estimate the barbiturate content of four samples of blood or urine in about two hours.
Method
A Hilger " uvispek " spectrophotometer was employed in the present work. Measurements of pH were made with a lithium glass electrode.
Five ml. of heparinized whole blood is placed in a 50-ml. glass-stoppered flask and shaken for three minutes in a mechanical shaker with 25 ml. of redistilled pure chloroform. The mixture is filtered through a Whatman No. 1 paper into a similar flask, and the residual sludge washed with a further 5 ml. of chloroform, the washings being filtered and combined with the main extract. The filtrate, which is clear but may be slightly yellow, is shaken for three minutes with 5 ml. of 0.050o aqueous sodium hydroxide. The mixture is transferred to a separating funnel; the chloroform layer is discarded and the aqueous layer collected into a test tube. After allowing time for chloroform droplets to settle, 4 ml. of of the solution is pipetted into a clean tube containing 2 ml. of 0.5 M borate buffer, pH 10. As a further precaution against chloroform contamination a fine stream of nitrogen is blown through the sample for 30 seconds. 
BARBITURATE INTOXICATION BY SPECTROPHOTOMETRY
The extraction procedure for urine, cerebrospinal fluid, and gastric contents is similar to that for blood except that the specimens are adjusted to approximately pH 6 before extraction, and the separation of the two phases after the initial chloroform extraction is performed by the use of a separating funnel, with subsequent filtration of the extract. For the estimation of barbiturates in tissues we have used 1 to 2 g. of wet sample homogenized with 10 ml. of phosphate buffer, pH 6, in a large glass homogenizer. The total volume is made up to 15 ml. and a 5-ml. aliquot extracted in the usual way. Troublesome emulsions frequently occur; we have not been able fully to overcome this difficulty by the use of other solvents as suggested by Goldbaum (1948) .
Calculation.-This is made after Walker, Fisher, and McHugh (1948) .
The barbiturate concentration in og. per ml. of the final extract (i.e., of the solution as measured in the spectrophotometer cell) is given by the expression The values for M and emax in the above expression clearly depend upon the particular barbiturate present. Where the actual compound is unknown we prefer to calculate its concentration provisionally in terms of barbital; since this substance has a low molecular weight and a high molecular extinction a conservative estimate is thereby obtained. In the special case of phenobarbitone a correction is necessary, since this derivative has an abnormally high absorption in acid solution. Fig. 1 represents the absorption spectra in alkaline and acid conditions of 5 ml. samples of blood from 10 normal subjects. In the absence of barbiturate it is seen that the absorption is practically the same in both acid and alkali at 239 mp,.
(This wavelength is the normal position of the barbiturate peak.)
These blood samples were used to determine the percentage recovery of varying concentrations of barbital added to 5 ml. samples. Over a concentration range of 100 to 250 jig. per 5 ml. (2 to 5 mg. per 100 ml.) the mean recovery in 17 estimations was 60% with a standard error of the mean of ±1. With concentrations below 100 Mug. per 5 ml. it was not always possible to determine the precise amount of barbital because an absorption peak at 239 m,u was not always observed owing to the relative preponderance of other chromogens. However, with experience of the method it is possible to make a fair estimate of barbiturate down to levels of 50 ,ug. per 5 ml. At concentrations above 250 Mg. per 5 ml. a lower recovery was obtained; thus the recovery is 55% at 600 Mug. per 5 ml., and about 50% with concentrations of 1,000 Mg. per 5 ml. (20 mg. per 100 ml.).
Since 60% is the recovery obtained over the range found in cases of intoxication, we have felt justified in correcting the final figure for this recovery (i.e., the experimental value is multiplied by 1.67). Using this correction factor, significant over-estimation of the blood level of barbiturate is unlikely. Recovery experiments have not been made on other compounds because it would appear from the work of Walker, Fisher, and McHugh (1948) Post-mortem material was obtained from Cases 3 and 4, these patients dying in hospital. Table II indicates the minimum barbiturate concentrations in some tissues examined by our method, and Fig.  4 illustrates the spectra obtained with extracts of blood and liver from Case 4.
Where interfering chromogens are present in high concentration, particularly with urine extracts, In Case 17 the presence of a preponderance of interfering substances in a urine extract can be inferred from the shift of the barbiturate peak to 235 my and from the high absorption in acid solution (Fig. 5) Lous (1950) , which is in turn based on both the procedures of Goldbaum (1948) and Walker et al. (1948) . We, however, use whole blood rather than serum, and in this respect, if heparin is the particoagulant, it is essential to use the pure product. Heparin as supplied for intramuscular use contains phenolic preservatives which absorb in alkaline solution over the critical range (Giotti and Maynert, 1951 In two fatal cases blood pentobarbital levels of 0.6 and 0.7 mg. per 100 ml. were found, but both patients were chronic alcoholics. Walker, Fisher, and McHugh discuss in some detail the identification of other drugs, notably salicylates and sulphonamides, which may interfere with the spectrophotometric estimation of barbiturate, and they mention the advisability of scanning the whole range between 220 and 300 m,u. They also state that picrotoxin, benzedrine, and caffeine do not interfere. This has also been our experience, but it is possible that xanthine derivatives contribute to the high levels of chromogens in urinary extracts.
Goldbaum (1948) also claimed a sensitivity of 0.4 mg. per 100 ml. of blood. He summarizes barbiturate analyses on seven fatal and three nonfatal cases. It is of some interest that in two fatal cases poisoned by seconal and pentobarbital respectively he found a concentration of barbiturate in the liver five times that in the blood. Born (1949) uses an ethanol-ether-alkali extraction technique; he mentions that the method is suitable for blood, but gives no clinical data. Giotti and Maynert (1951) used an ether extraction method for studying the renal clearance of barbital in dogs. By treating their ether extracts of blood and urine with activated charcoal they achieved considerable reduction in interfering chromogens without significant loss of barbital. It is doubtful whether this refinement can be applied in the case of all barbiturates, particularly where chloroform is the solvent. Summary A modification of existing methods for the ultra-violet spectrophotometric estimation of barbiturates in biological fluids and tissues is described.
Seventeen cases of barbiturate intoxication are recorded; blood and urine barbiturate levels appear to be related to the degree of depression of the nervous system.
Blood barbital levels up to 10 mg. per 100 ml. and phenobarbitone levels up to 5 mg. per 100 ml. may be compatible with consciousness, whereas coma is usually produced with levels of shortacting barbiturates of only 1 to 2 mg. per 100 ml. Alcoholic intoxication may be a complicating factor.
Urinary clearance is low for phenobarbitone, good for quick-acting barbiturates, and high for barbital.
